Androgen Excess in Women: Proteomic and Metabolomic Approaches.

2区 医学 Q2 Medicine Frontiers of Hormone Research Pub Date : 2019-01-01 DOI:10.1159/000494910
M. Insenser, H. Escobar-Morreale
{"title":"Androgen Excess in Women: Proteomic and Metabolomic Approaches.","authors":"M. Insenser, H. Escobar-Morreale","doi":"10.1159/000494910","DOIUrl":null,"url":null,"abstract":"Most research efforts addressing the pathophysiology of polycystic ovary syndrome (PCOS) applied targeted approaches focusing on specific genes and/or proteins that were selected on the basis of previous knowledge about their putative roles in metabolic and signalling pathways. On the contrary, the use of nontargeted approaches is not constricted by previous knowledge on the issue and offers the potential advantage of revealing novel associations with unexpected molecules that might lead to new mechanistic explanations for the etiology and the pathophysiology of PCOS. To date, several \"omics\" approaches have been applied to create a holistic picture complementing the information generated by genetic studies. Proteomics and metabolomics have the potential advantage over genomics of integrating genetic and epigenetic influences, thereby facilitating interpretation of the molecular mechanisms and pathways involved in the pathogenesis of PCOS. This chapter summarizes recent advances provided by proteomic and metabolomic studies addressing PCOS and aims to offer a critical yet balanced review of the studies published to date.","PeriodicalId":50428,"journal":{"name":"Frontiers of Hormone Research","volume":"53 1","pages":"162-176"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000494910","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers of Hormone Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000494910","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Most research efforts addressing the pathophysiology of polycystic ovary syndrome (PCOS) applied targeted approaches focusing on specific genes and/or proteins that were selected on the basis of previous knowledge about their putative roles in metabolic and signalling pathways. On the contrary, the use of nontargeted approaches is not constricted by previous knowledge on the issue and offers the potential advantage of revealing novel associations with unexpected molecules that might lead to new mechanistic explanations for the etiology and the pathophysiology of PCOS. To date, several "omics" approaches have been applied to create a holistic picture complementing the information generated by genetic studies. Proteomics and metabolomics have the potential advantage over genomics of integrating genetic and epigenetic influences, thereby facilitating interpretation of the molecular mechanisms and pathways involved in the pathogenesis of PCOS. This chapter summarizes recent advances provided by proteomic and metabolomic studies addressing PCOS and aims to offer a critical yet balanced review of the studies published to date.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
女性雄激素过量:蛋白质组学和代谢组学方法。
针对多囊卵巢综合征(PCOS)病理生理学的大多数研究都采用靶向方法,重点关注特定基因和/或蛋白质,这些基因和/或蛋白质是根据先前对其在代谢和信号通路中的假定作用的了解而选择的。相反,非靶向方法的使用不受先前关于该问题的知识的限制,并且提供了揭示意想不到的分子的新关联的潜在优势,这些分子可能导致PCOS的病因和病理生理的新的机制解释。迄今为止,几种“组学”方法已被应用于创建一个整体的图片,以补充遗传研究产生的信息。与基因组学相比,蛋白质组学和代谢组学具有整合遗传和表观遗传影响的潜在优势,从而有助于解释多囊卵巢综合征发病的分子机制和途径。本章总结了针对多囊卵巢综合征的蛋白质组学和代谢组学研究的最新进展,旨在对迄今为止发表的研究进行批判性而平衡的回顾。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Frontiers of Hormone Research
Frontiers of Hormone Research 医学-内分泌学与代谢
自引率
0.00%
发文量
0
期刊介绍: A series of integrated overviews on cutting-edge topics New sophisticated technologies and methodological approaches in diagnostics and therapeutics have led to significant improvements in identifying and characterizing an increasing number of medical conditions, which is particularly true for all aspects of endocrine and metabolic dysfunctions. Novel insights in endocrine physiology and pathophysiology allow for new perspectives in clinical management and thus lead to the development of molecular, personalized treatments. In view of this, the active interplay between basic scientists and clinicians has become fundamental, both to provide patients with the most appropriate care and to advance future research.
期刊最新文献
Endocrine and Metabolic Late Effects in Cancer Survivors Cardiometabolic Risk, Part 1: Chemotherapy and Radiotherapy - Old Foes Still Threatening Cancer Survivors? Hypothalamic-Pituitary Dysfunctions Other Than Growth Hormone Deficiency in Cancer Survivors. Diabetes in Cancer Patients: Risks, Goals and Management. Thyroid Dysfunction and Thyroid Cancer in Childhood Cancer Survivors: Prevalence, Surveillance and Management.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1